XAIR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.82
Market Cap (MRQ) $2M
P/E (TTM) -0.2
EPS (TTM) $-13.48
Revenue (TTM) $8M
ROE (TTM) -561.8%
52W Range $2–$56

XAIR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
July 13, 2026 1-for-20 Reverse
July 14, 2025 1-for-20 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$8M
2019-03-31 → 2026-03-31
EPS$-4.01
2017-12-31 → 2026-03-31
Free Cash Flow$-19M
2019-03-31 → 2026-03-31
Net margin-435.7%
2017-12-31 → 2026-03-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend XAIR 5Y avg Peer Median Verdict
P/E (TTM) -0.25Y avg ≈-24.9 ≈-24.9 · ·
P/S (TTM) 0.35Y avg ≈1861.7 ≈1861.7 2.4 Undervalued
P/B (MRQ) 1.05Y avg ≈52.5 ≈52.5 0.3 Undervalued
Price / FCF (TTM) -0.15Y avg ≈-62.4 ≈-62.4 · ·
Price / Cash Flow (TTM) -0.15Y avg ≈-67.8 ≈-67.8 · ·
Price / Tangible Book 0.35Y avg ≈55.3 ≈55.3 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Beat Rate 50.0%
Avg Surprise -4.5%
Next Report Nov 09, 2026
PeriodReportEPS ActualEPS EstSurprise
March 31, 2027 Aug 13, 2026 $-11.00 $-11.02 0.15%
Dec. 31, 2026 Jun 15, 2026 $-12.60 $-11.56 -9.0%
June 30, 2026 Aug 13, 2026 $-10.79 $-11.22 3.8%
March 31, 2026 $-12.60 $-11.56 -9.0%
Dec. 31, 2025 $-16.60 $-16.68 0.46%
Sept. 30, 2025 $-25.00 $-17.44 -43.3%
June 30, 2025 $-30.60 $-28.56 -7.1%
March 31, 2025 $-36.00 $-49.78 27.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 20262025202420232022202120202019
Revenue $8M$4M$1M··$873.0K$1M$8M
Cost of Revenue $7M$5M$2M$555.0K····
Gross Profit $252.0K$-2M$-1M$-555.0K····
R&D Expense $10M$17M$24M$17M$12M$13M$11M$4M
SG&A Expense $19M$26M$37M$35M$18M$10M$9M$7M
Operating Expenses $29M$43M$62M$52M$41M···
Operating Income $-29M$-45M$-63M$-52M$-41M$-22M$-18M$-3M
Interest Expense ··$3M$30.0K$775.0K$642.0K$30.5K$1.5K
Interest Income $303.0K$705.0K······
Other Non-op $-14.0K$9.0K$-169.0K$-7M$-3M$-661.0K$-2M$-3.0K
Pretax Income $-34M$-48M$-64M$-59M$-44M$-23M$-20M$-7M
Income Tax ······$-154.3K·
Net Income $-33M$-47M$-60M$-56M$-43M$-23M$-20M$-7M
EPS (Basic) $-4.01$-13.77$-1.82$-1.86$-1.68$-1.27·$-0.77
EPS (Diluted) $-4.01$-13.77$-1.82$-1.86···$-0.77
Shares (Basic) 8,300,9163,385,32733,160,18029,973,63925,668,23018,005,226,000·8,498,525
Shares (Diluted) 8,300,9163,385,32733,160,18029,973,639···8,498,525
EBITDA $-29M$-45M$-63M$-52M$-40M·$-18M$-3M
Balance Sheet 28
Metric Trend 20262025202420232022202120202019
Cash & Equivalents $7M$5M$11M$29M$80M$35M$20M$1M
Short-term Investments $5M$2M$23M$17M···$7M
Receivables $1M$710.0K$319.0K·$322.0K$425.0K··
Inventory $1M$2M$2M$1M$350.0K···
Prepaid Expense $5M$6M$7M$4M$2M$2M$1M$788.4K
Other Current Assets $190.0K$203.0K······
Current Assets $25M$16M$44M$59M$93M$37M$27M$9M
PP&E (Net) $8M$11M$9M$5M$2M$929.0K$211.3K$244.9K
PP&E (Gross) $16M$17M$12M$6M$3M$1M$491.0K$447.4K
Accum. Depreciation $8M$6M$3M$1M$767.0K$453.0K$279.7K$202.5K
Intangibles $1M$1M$1M$2M$2M$346.0K··
Other Non-current Assets $158.0K$103.0K$113.0K$212.0K$207.0K$138.0K··
Total Assets $35M$30M$57M$69M$99M$41M$27M$9M
Accounts Payable $2M$2M$2M$2M$1M$1M$2M$1M
Accrued Liabilities ···$17M$8M$2M$1M$2M
Current Liabilities $7M$5M$12M$20M$11M$4M$5M$5M
Capital Leases $1M$1M$2M$2M$2M$2M$131.6K·
Other Non-current Liabilities ···$4M····
Total Liabilities $29M$16M$30M$27M$21M$10M$9M$5M
Long-term Debt ··$18M$200.0K$200.0K$4M··
Common Stock ··$5.0K$3.0K$3.0K$2.0K$1.6K$871
Paid-in Capital $326M$300M$265M$217M$196M$111M$76M$42M
Retained Earnings $-320M$-286M$-240M$-179M$-124M$-80M$-58M$-38M
Treasury Stock $25.0K$25.0K$25.0K$25.0K$25.0K$25.0K$25.0K$25.0K
AOCI $134.0K$-60.0K$-15.0K$53.0K$96.0K···
Stockholders' Equity $6M$14M$25M$38M$73M$30M$18M$4M
Liabilities + Equity $35M$30M$57M$69M$99M$41M$27M$9M
Shares Outstanding 589,6394,128,53945,900,82130,738,58529,886,17321,828,24416,056,3608,714,815
Cash Flow 13
Metric Trend 20262025202420232022202120202019
D&A $3M$3M$2M$600.0K$314.0K$173.0K$77.2K$64.8K
Stock-based Comp $5M$9M$21M$20M$8M$5M$4M$2M
Amort. of Intangibles $204.0K$205.0K$205.0K$205.0K$38.0K···
Other Non-cash ····$12M·$955.4K$5M
Operating Cash Flow $-18M$-38M$-56M$-33M$-23M$-20M$-15M$1M
CapEx $1M$6M$6M$4M$1M$890.0K$43.6K$56.5K
Investing Cash Flow $-4M$15M$-12M$-21M$-1M$-890.0K$4M$-2M
Stock Issued $4M$19M··$25M··$799.2K
Net Stock Activity $4M$19M··$25M··$799.2K
Financing Cash Flow $29M$17M$43M$3M$79M$30M$35M$1M
Net Change in Cash $7M$-7M$-25M$-51M$55M$10M$24M$618.9K
Free Cash Flow $-19M$-44M$-62M$-37M$-25M·$-15M$1M
Levered FCF ······$-15M·
Profitability 8
Metric Trend 20262025202420232022202120202019
Gross Margin 3.3%-44.9%-112.8%·····
Operating Margin -378.2%-1202.1%-5436.2%···-1305.1%-39.6%
Net Margin -433.0%-1258.4%-5197.8%···-1434.6%-84.9%
Pretax Margin -447.1%-1308.5%-5547.4%···-1445.7%·
EBITDA Margin -378.2%-1202.1%-5436.2%···-1293.6%-38.8%
ROA -101.6%-107.2%-95.8%-66.5%-61.8%·-108.2%-69.8%
ROE -337.4%-241.4%-191.4%-100.9%-81.3%·-132.5%-202.4%
ROIC ······-101.0%·
Liquidity & Solvency 3
Metric Trend 20262025202420232022202120202019
Current Ratio 3.83.23.83.08.7·5.51.6
Quick Ratio 2.01.53.02.37.5·4.11.5
Interest Coverage ··-21.6-1735.3-52.5·-594.0·
Efficiency 3
Metric Trend 20262025202420232022202120202019
Asset Turnover 0.20.10.0···0.10.8
Inventory Turnover 3.92.41.50.8····
Receivables Turnover 8.67.27.3·····
Per Share 5
Metric Trend 20262025202420232022202120202019
Book Value / Share $0.52$0.16$0.55$1.23$2.43·$1.13$0.46
Revenue / Share $0.93$0.05$0.04····$0.91
Cash Flow / Share $-2.19$-0.56$-1.69····$0.16
Cash / Share $0.57$0.06$0.25$0.95$2.69·$1.24$0.15
EPS (TTM) $-4.01$-0.69$-1.82$-1.86···$-0.77
Growth Rates 3
Metric Trend 20262025202420232022202120202019
Revenue YoY 107.3%219.7%······
Revenue CAGR 3Y ··9.9%·····
Revenue CAGR 5Y 54.5%·······
Valuation (TTM) 10
Metric Trend 20262025202420232022202120202019
Revenue TTM $8M$4M$1M$1M$1M$873.0K$1M$8M
Net Income TTM $-33M$-47M$-60M$-56M$-43M$-23M$-20M$-7M
Market Cap $8M$451M$1.60B$4.15B$3.99B·$2.57B$837M
P/E -0.2-7.9-19.1-72.6···-124.7
P/S 1.1121.71378.23980.43827.3·1848.1108.3
P/B 1.333.263.8109.454.9·142.0207.9
P / Tangible Book 1.636.567.6114.456.379.7··
P / Cash Flow -0.4-11.8-28.5-125.7-172.5·-168.5623.9
P / FCF -0.4-10.2-25.9-112.5-162.8·-168.0651.3
Earnings Yield -581.2%-12.6%-5.2%-1.4%···-0.80%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2026-03-312025-03-312024-03-312023-03-312022-03-31
Revenue $8M $4M $1M · ·
Gross Margin % 3.3% -44.9% -112.8% · ·
Operating Margin % -378.2% -1202.1% -5436.2% · ·
Net Income $-33M $-47M $-60M $-56M $-43M
Diluted EPS $-4.01 $-13.77 $-1.82 $-1.86 ·

Institutional owners (13F) 32 filers · $836K total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 32
Value held $836K
New positions 5
Exited positions 5
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (-1 vs prior Q) 5 (+2 vs prior Q) 2 (0 vs prior Q) 6 (-3 vs prior Q) -16K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Balyasny Asset Management L.P. $206,969 464,161 24.75% Shares
LASRY MARC $189,305 81,950 22.64% Shares
Murchinson Ltd. $122,269 274,208 14.62% Shares
Daytona Street Capital LLC $61,454 151,550 7.35% Shares
GEODE CAPITAL MANAGEMENT, LLC $50,049 112,242 5.99% Shares
VANGUARD GROUP INC $43,877 60,437 5.25% Shares
Bleichroeder LP $38,565 86,489 4.61% Shares
VANGUARD CAPITAL MANAGEMENT LLC $27,982 62,741 3.35% Shares
COMMONWEALTH EQUITY SERVICES, LLC $21,130 47,382 2.53% Shares
VANGUARD FIDUCIARY TRUST CO $13,098 29,368 1.57% Shares
StoneX Group Inc. $9,971 21,559 1.19% Shares
BlackRock, Inc. $9,825 22,033 1.18% Shares
XTX Topco Ltd $7,882 17,677 0.94% Shares
NORTHERN TRUST CORP $7,601 17,046 0.91% Shares
WEALTH EFFECTS LLC $7,565 16,965 0.90% Shares
BALDWIN WEALTH PARTNERS LLC/MA $6,599 14,800 0.79% Shares
Kaye Capital Management $4,514 26,200 0.54% Shares
OSAIC HOLDINGS, INC. $3,649 8,116 0.44% Shares
Tower Research Capital LLC (TRC) $2,043 4,582 0.24% Shares
PFS Partners, LLC $892 2,000 0.11% Shares
IFP Advisors, Inc $507 1,136 0.06% Shares
NewEdge Advisors, LLC $204 457 0.02% Shares
GROUP ONE TRADING LLC $60 135 0.01% Shares
GODSEY & GIBB, INC $23 50 0.00% Shares
MORGAN STANLEY $18 40 0.00% Shares
BNP PARIBAS FINANCIAL MARKETS $18 41 0.00% Shares
CWM, LLC $17 25 0.00% Shares
JPMORGAN CHASE & CO $15 32 0.00% Shares
FMR LLC $11 25 0.00% Shares
HRT FINANCIAL LP $9 21,097 0.00% Shares
JONES FINANCIAL COMPANIES LLLP $5 10 0.00% Shares
UBS Group AG $4 9 0.00% Shares

Company insiders 17 insiders · 10 officers · 10 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Robert Scott Goodman Chief Executive Officer July 29, 2026 P 34,822 1 0 $199,999
Steven A. Lisi CEO and Chairman of the Board Nov. 4, 2025 A 3,327,411 0 0 $0
Daniel J Moorhead Chief Financial Officer July 29, 2026 P 4,340 1 0 $24,998
Douglas Quinton Larson Chief Financial Officer Nov. 4, 2025 A 27,548 0 0 $0
Douglas Beck Chief Financial Officer June 16, 2021 P 22,460 0 0 $0
Haim Aviv Chief Financial Officer May 15, 2017 A · 0 0 $0
Michael A. Gaul Chief Operating Officer Nov. 4, 2025 A 94,150 0 0 $0
Amir Avniel Chief Business Officer March 20, 2024 A 0 0 0 $0
Jeff Lynn Myers Chief Medical Officer Dec. 27, 2023 S 46,577 0 0 $0
David Grossman Secretary Feb. 16, 2018 M 4,008 0 0 $0
Yoori Lee Director Nov. 4, 2025 A 12,654 0 0 $0
Erick Lucera Director Nov. 4, 2025 A 43,608 0 0 $0
William P Forbes Director Nov. 4, 2025 A 14,855 0 0 $0
Robert Carey Director Nov. 3, 2025 A 4,076,864 0 0 $0
Ron Bentsur Director Nov. 22, 2024 A 144,736 0 0 $0
Ari Raved Director June 22, 2018 S 565,885 0 0 $0
Yi-Chien Lin 10% owner Oct. 1, 2026 P 145,393 3 0 $56,590

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 62,741 SH Aug. 19, 2026 Daily

XAIR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts BUY
Median target $20.00 +609.2%
2 28.6% Strong Buy
4 57.1% Buy
1 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

2 analysts · 2026-09-29

Mean target $20.00 +609.2%

← Below all targets Current price $2.82
Low$10.00 Mean$20.00 High$30.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
XAIR $8M -0.2 107.3% -433.0% -337.4% 3.3%
NXL $11M -1.1 78.8% -2725.8% -169.3% 79.7%
IVF · -0.0 4.7% · · ·
TNON · · · · · ·
BJDX $403.2K -0.0 · · -121.6% ·
ADGM · -0.7 · · · ·
ABT $250.18B 33.7 5.7% 14.7% 13.1% ·

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026